These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21755575)

  • 1. Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis.
    Numasawa Y; Kimura T; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Ogawa S; Umezawa A
    Stem Cells; 2011 Sep; 29(9):1405-14. PubMed ID: 21755575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
    Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
    Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function.
    Otto Beitnes J; Oie E; Shahdadfar A; Karlsen T; Müller RM; Aakhus S; Reinholt FP; Brinchmann JE
    Cell Transplant; 2012; 21(8):1697-709. PubMed ID: 22410280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes.
    Tsuji H; Miyoshi S; Ikegami Y; Hida N; Asada H; Togashi I; Suzuki J; Satake M; Nakamizo H; Tanaka M; Mori T; Segawa K; Nishiyama N; Inoue J; Makino H; Miyado K; Ogawa S; Yoshimura Y; Umezawa A
    Circ Res; 2010 May; 106(10):1613-23. PubMed ID: 20508201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient cardiomyogenic differentiation of bone marrow mesenchymal stromal cells by combination of Wnt11 and bone morphogenetic protein 2.
    Zhang Z; Li H; Ma Z; Feng J; Gao P; Dong H; Zhang Z
    Exp Biol Med (Maywood); 2012 Jul; 237(7):768-76. PubMed ID: 22829700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
    Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
    Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-independent cardiomyogenic transdifferentiation in human endometrium-derived mesenchymal cells.
    Ikegami Y; Miyoshi S; Nishiyama N; Hida N; Okamoto K; Miyado K; Segawa K; Ogawa S; Umezawa A
    Artif Organs; 2010 Apr; 34(4):280-8. PubMed ID: 20420609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
    Ma DC; Yang ZJ; Wang W; Xu SL; Zhang YQ; Zhou F; Chen B; Xu ZQ; Cao KJ; Ma WZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):119-22. PubMed ID: 16626576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.